
Zynex ZYXI
Quartalsbericht 2025-Q3
hinzugefügt 17.11.2025
Zynex Langfristige Verbindlichkeiten 2011-2026 | ZYXI
Langfristige Verbindlichkeiten Jährlich Zynex
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 3.43 M | 531 K | 12 K | 148 K | 228 K | 324 K | 2.69 M | 1.79 M | 1.9 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.43 M | 12 K | 1.23 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
AxoGen
AXGN
|
1.61 M | $ 31.65 | -5.55 % | $ 1.4 B | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
CONMED Corporation
CNMD
|
877 M | $ 43.45 | 1.31 % | $ 1.34 B | ||
|
Abiomed
ABMD
|
19.1 M | - | - | $ 17.2 B | ||
|
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 9.76 | 1.99 % | $ 701 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.92 | 12.33 % | $ 136 M | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 17.97 | -20.68 % | $ 2.57 B | ||
|
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | ||
|
Bio-Rad Laboratories
BIO
|
1.35 B | $ 322.91 | -0.16 % | $ 9.11 B | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 53.33 | -2.07 % | $ 7.95 K | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 95.53 | -2.13 % | $ 141 B | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.1 | 11.41 % | $ 153 M | ||
|
Abbott Laboratories
ABT
|
25.7 B | $ 124.29 | -1.27 % | $ 216 B | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 13.09 | -3.61 % | $ 1.01 B | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.49 | 29.56 % | $ 24 M | ||
|
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
8.87 K | $ 28.66 | -0.49 % | $ 242 M | ||
|
InMode Ltd.
INMD
|
12 M | $ 14.49 | 0.35 % | $ 1.15 B | ||
|
Pulmonx Corporation
LUNG
|
25 M | $ 2.0 | -2.21 % | $ 78.2 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
184 M | $ 171.78 | -0.58 % | $ 12.9 B | ||
|
Accuray Incorporated
ARAY
|
196 M | $ 0.88 | -0.46 % | $ 90.4 M | ||
|
IRadimed Corporation
IRMD
|
4.76 M | $ 97.57 | -1.39 % | $ 1.24 B | ||
|
OrthoPediatrics Corp.
KIDS
|
84.7 M | $ 20.12 | 9.89 % | $ 464 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 15.66 | 4.96 % | $ 423 M | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 18.6 | 0.27 % | $ 122 M | ||
|
Myomo
MYO
|
275 K | $ 0.99 | 0.29 % | $ 6.98 M | ||
|
Globus Medical
GMED
|
18.2 M | $ 91.33 | -3.28 % | $ 12.4 B |